Wednesday, November 25, 2009, 3:08am SGT - The Singapore stock market opens in 5 hours and 52 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Sanofi-Aventis (SNY)

At 2:53AM SGT: 38.4901 USD  Down 0.1299 (0.34%)  
 MORE ON SNY 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 SANOFI-AVENTIS SA (NYSE:SNY) Delayed quote dataEdit
Last Trade:38.4901 USD
Trade Time:2:53AM SGT
Change:Down 0.1299 (0.34%)
Prev Close:38.62
Open:38.67
Bid:N/A
Ask:N/A
1y Target Est:43.50
Day's Range:38.33 - 38.78
52wk Range:24.59 - 40.17
Volume:520,651
Avg Vol (3m):1,420,670
Market Cap:100.50B
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:1.419 (3.67%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add SNY to Portfolio   Download Data

 HEADLINES 
•Novartis 'Cells' Its Flu Vaccine Technology
at CNBC (Wed 1:52am)
•Cramer's Lightning Round: Sensational Ciena (11/23/09)
at Seeking Alpha (Tue 7:51pm)
•Lightning Round: AT&T, Verizon, Novartis and More
at CNBC (Tue 8:56am)
•'Mad Money Lightning Round': Ciena's a Bargain
at TheStreet.com (Tue 8:30am)
•Cramer's 'Mad Money' Recap: The Next Leg in the Housing Rally (Final)
at TheStreet.com (Tue 7:49am)
•The Side Effect of Developing Obesity Drugs
at Motley Fool (Tue 5:13am)
•Biotech Stocks: Europe drug stocks rally; U.S. indexes mixed
at MarketWatch (Tue 2:03am)
•Biotech Stocks: Europe drug stocks rally; Cephalon slides
at MarketWatch (Mon, Nov 23)
•Sanofi chief lays out distinctive strategy
at FT.com (Mon, Nov 23)
•Sanofi-Aventis Falling Off a Patent Cliff?
at CNBC (Sat, Nov 21)
•Cramer's 'Mad Money' Recap: Next Week's Game Plan (Update 2)
at TheStreet.com (Sat, Nov 21)
•[video] The Right Formula?
at CNBC (Sat, Nov 21)
•Pozen Initiates Phase III on PA325/40
Zacks.com (Sat, Nov 21)
•Pfizer's Generics Business Takes Shape
at The Wall Street Journal Online (Sat, Nov 21)
•AstraZeneca Seeks FDA Approval
Zacks.com (Fri, Nov 20)
•4-Star Stocks Poised to Pop: Merck
at Motley Fool (Fri, Nov 20)
•Competition in Blood-Thinners: Win-Win for Everyone Involved
at Seeking Alpha (Fri, Nov 20)
•Pfizer Dodges a Bullet
at Motley Fool (Fri, Nov 20)
More Headlines for SNY...
 ANALYST 
EPS Est (next year) (Dec-09) :4.76
EPS Est (in 2 years) (Dec-10) :4.92
Avg Rec (current)*:2.0
PEG Ratio:2.53
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Sanofi-Aventis, a pharmaceutical company, contributes to enhancing life by providing an offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices